Introduction
Fair Balance
:
FDA requires manufactures to
prominently communicate risks of the drug in a
way that is comparable in scope, depth and detail
to communication of benefits
In 2009-
FDA issued
Draft Guidance for Industry:
Presenting Risk Information in Prescription Drug
and Medical Device Promotion
FDA regulations provide some examples of
"lacking in fair balance"—but the 2009 draft
guidance is a guide to OPDP's expectation on this
topic
3